Inter Pharma PCL (BKK:IP)
Thailand flag Thailand · Delayed Price · Currency is THB
4.160
+0.020 (0.48%)
May 22, 2026, 4:36 PM ICT

Inter Pharma PCL Balance Sheet

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
303.8280.64184.6412.39776.42173.87
Short-Term Investments
1.211.010.930.860.830.8
Cash & Short-Term Investments
305.01281.65185.53413.25777.25174.67
Cash Growth
-7.63%51.81%-55.10%-46.83%344.99%14.09%
Accounts Receivable
352.78374.86376.06337.32340.3258.11
Other Receivables
100.8981.8271.3787.7451.8934.08
Receivables
453.67456.68447.43425.06392.2292.25
Inventory
393.05358.78339.49351.82332.98192
Other Current Assets
9.178.89.3512.7212.787.7
Total Current Assets
1,1611,106981.81,2031,515666.61
Property, Plant & Equipment
1,2021,2101,150929.27880.77457.32
Long-Term Investments
36.2936.2941.7843.379.3510.12
Goodwill
563.1563.1563.1477.85477.8522.16
Other Intangible Assets
217.04219.82217.36197.36167.7955.1
Long-Term Accounts Receivable
1.512.06----
Long-Term Deferred Tax Assets
22.8520.9420.1715.919.818.98
Other Long-Term Assets
71.5480.4752.1685.7529.52106.76
Total Assets
3,2753,2393,0272,9523,0901,327
Accounts Payable
230.6212.98184.6200.52193.7969.65
Accrued Expenses
47.760.5246.0347.0634.7415.92
Short-Term Debt
104.32119.3379.9146.3448.73131.01
Current Portion of Long-Term Debt
64.2762.4255.254.4372.5135.62
Current Portion of Leases
30.5232.8326.6438.8930.460.57
Current Income Taxes Payable
36.9324.5311.844.1125.1814.8
Current Unearned Revenue
8.635.334.59---
Other Current Liabilities
122.49120.08117.4787.3992.5568.06
Total Current Liabilities
645.47638.02526.29478.75497.95335.63
Long-Term Debt
124.12124.45167.19205.46319.61187.06
Long-Term Leases
53.7861.9165.554.8367.691.9
Pension & Post-Retirement Benefits
51.0548.8540.8832.7531.1415.41
Long-Term Deferred Tax Liabilities
53.2254.6160.8859.2155.333.53
Other Long-Term Liabilities
8.9911.998.323.662.14-
Total Liabilities
936.62939.83869.06834.65973.86543.54
Common Stock
302.67302.67302.67186.26186.26149.01
Additional Paid-In Capital
1,4981,4981,4981,4981,498492.09
Retained Earnings
290.48254.69131.79225.25238.26116.85
Comprehensive Income & Other
3.73.73.73.73.73.7
Total Common Equity
2,0952,0591,9361,9131,926761.64
Minority Interest
243.43239.94221.66204.53190.2521.86
Shareholders' Equity
2,3382,2992,1582,1182,116783.5
Total Liabilities & Equity
3,2753,2393,0272,9523,0901,327
Total Debt
377.01400.94394.45399.95539356.17
Net Cash (Debt)
-72-119.29-208.9213.3238.25-181.5
Net Cash Growth
----94.42%--
Net Cash Per Share
-0.12-0.20-0.350.020.45-0.38
Filing Date Shares Outstanding
605.34605.34605.34605.35605.35484.27
Total Common Shares Outstanding
605.34605.34605.34605.35605.35484.27
Working Capital
515.44467.9455.51724.11,017330.98
Book Value Per Share
3.463.403.203.163.181.57
Tangible Book Value
1,3151,2761,1561,2381,281684.38
Tangible Book Value Per Share
2.172.111.912.052.121.41
Land
-333.9333.9327.63327.63183.25
Buildings
-629.85534.98430.08404.55177.13
Machinery
-398.23380.51346.66310.51148.3
Construction In Progress
-162.42174.8557.1715.970.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.